MoatScan.ai
Novonesis (Novozymes) A/S
NSIS-B.CO · Moat type: UNBESTIMMT
Fair Value
465 DKK (≈ 71.08 USD)
Novonesis (formerly Novozymes, merged with Chr. Hansen) is a Danish biosolutions conglomerate that develops and markets biological solutions – enzymes, microorganisms, and fermentation products – for industries such as agriculture, food, detergents, bioenergy, and pharmaceuticals, with recurring demand for specialized biological active ingredients supporting the revenue model.
View full analysis →
🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.
Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.